The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions

To collect prospective observational data on patients undergoing ESD, EFTR or STER for UGI neoplastic lesions

• Lesion characteristics including histology
• Procedural outcomes
• Safety Outcomes
• Efficacy outcomes

Inclusion Criteria:

• UGI neoplastic lesions > 10mm

  • Lesions for ESD limited to the mucosal and/or submucosal layer OR
  • Lesions for EFTR limited to the muscularis propria layer OR
  • Lesions for STER limited to the submucosal and/or muscularis propria layer

• Aged 18 years or older

Exclusion Criteria:

• Age less than 18
• Unable to give informed consent
• Pregnant or lactating patients
• Patients with bleeding diathesis or who cannot discontinue ADP blockers (e.g. clopidogrel, prasugrel) or antithrombotics (e.g. warfarin, dabigatran) periprocedurally